Mu-Sheng Zeng (Musheng Zeng)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 56

Top Venues

Nature communications

PLoS pathogens

Signal transduction and targeted therapy

Journal of virology

This page only lists publications with an associated author ORCID identifier.

Publications

Ling Zhong, Wanlin Zhang, Hong Liu, Xinyu Zhang, Zeyu Yang, Zhenfu Wen, Ling Chen, Haolin Chen, Yanran Luo, Yanhong Chen, Qisheng Feng, Mu-Sheng Zeng, Qinjian Zhao, Lixin Liu, Claude Krummenacher, Yi-Xin Zeng, Yongming Chen, Xiaoxue Chen, Xiao Zhang
A cocktail nanovaccine targeting key entry glycoproteins elicits high neutralizing antibody levels against EBV infection. Nature communications 15 (1) (2024)
Jie Yang, Qiao-Li Wang, Guan-Nan Wang, Jia-Cong Ye, Zi-Qian Li, Jing-Yun Wang, Zhao-Hui Liang, Shu-Xin Li, Cong Sun, Wen-Ting Liao, Yi-Jun Gao, Jing Wang, Yong Mao, Chunjing Yu, Guo-Kai Feng, Mu-Sheng Zeng
A pan-KRAS degrader for the treatment of KRAS-mutant cancers. Cell discovery 10 (1) (2024)
Ling Zhong, Wanlin Zhang, Hong Liu, Xinyu Zhang, Zeyu Yang, Zhenfu Wen, Ling Chen, Haolin Chen, Yanran Luo, Yanhong Chen, Qisheng Feng, Mu-Sheng Zeng, Qinjian Zhao, Lixin Liu, Claude Krummenacher, Yi-Xin Zeng, Yongming Chen, Xiaoxue Chen, Xiao Zhang
A cocktail nanovaccine targeting key entry glycoproteins elicits high neutralizing antibody levels against EBV infection. Nature communications 15 (1) (2024)
Chu Xie, Cong Sun, Mu-Sheng Zeng
Navigating Epstein-Barr virus autoimmunity: role of NK cells and T cells in multiple sclerosis. Signal transduction and targeted therapy 9 (1) (2024)
Ling Zhong, Wanlin Zhang, Hong Liu, Xinyu Zhang, Zeyu Yang, Zhenfu Wen, Ling Chen, Haolin Chen, Yanran Luo, Yanhong Chen, Qisheng Feng, Mu-Sheng Zeng, Qinjian Zhao, Lixin Liu, Claude Krummenacher, Yi-Xin Zeng, Yongming Chen, Xiaoxue Chen, Xiao Zhang
A cocktail nanovaccine targeting key entry glycoproteins elicits high neutralizing antibody levels against EBV infection. Nature communications 15 (1) (2024)
Chu Xie, Cong Sun, Mu-Sheng Zeng
Navigating Epstein-Barr virus autoimmunity: role of NK cells and T cells in multiple sclerosis. Signal transduction and targeted therapy 9 (1) (2024)
Hui-Lan Li, Lan-Yi Zhong, Yin-Feng Kang, Yan-Lan Yang, Liang Shi, Ai-Xia Zhai, Chao Wu, Mu-Sheng Zeng, Qian-Ying Zhu
Evaluation of serum Epstein-Barr virus envelope glycoproteins antibodies and their association with systemic autoimmune diseases. Journal of medical virology 96 (4) (2024)
Jie Yang, Qiao-Li Wang, Guan-Nan Wang, Jia-Cong Ye, Zi-Qian Li, Jing-Yun Wang, Zhao-Hui Liang, Shu-Xin Li, Cong Sun, Wen-Ting Liao, Yi-Jun Gao, Jing Wang, Yong Mao, Chunjing Yu, Guo-Kai Feng, Mu-Sheng Zeng
A pan-KRAS degrader for the treatment of KRAS-mutant cancers. Cell discovery 10 (1) (2024)
Jie Yang, Qiao-Li Wang, Guan-Nan Wang, Jia-Cong Ye, Zi-Qian Li, Jing-Yun Wang, Zhao-Hui Liang, Shu-Xin Li, Cong Sun, Wen-Ting Liao, Yi-Jun Gao, Jing Wang, Yong Mao, Chunjing Yu, Guo-Kai Feng, Mu-Sheng Zeng
A pan-KRAS degrader for the treatment of KRAS-mutant cancers. Cell discovery 10 (1) (2024)
Chu Xie, Cong Sun, Mu-Sheng Zeng
Navigating Epstein-Barr virus autoimmunity: role of NK cells and T cells in multiple sclerosis. Signal transduction and targeted therapy 9 (1) (2024)
Chu Xie, Cong Sun, Mu-Sheng Zeng
Navigating Epstein-Barr virus autoimmunity: role of NK cells and T cells in multiple sclerosis. Signal transduction and targeted therapy 9 (1) (2024)
Ling Zhong, Wanlin Zhang, Hong Liu, Xinyu Zhang, Zeyu Yang, Zhenfu Wen, Ling Chen, Haolin Chen, Yanran Luo, Yanhong Chen, Qisheng Feng, Mu-Sheng Zeng, Qinjian Zhao, Lixin Liu, Claude Krummenacher, Yi-Xin Zeng, Yongming Chen, Xiaoxue Chen, Xiao Zhang
A cocktail nanovaccine targeting key entry glycoproteins elicits high neutralizing antibody levels against EBV infection. Nature communications 15 (1) (2024)
Xiao-Dong Dong, Yan Li, Ying Li, Cong Sun, Shang-Xin Liu, Hao Duan, Run Cui, Qian Zhong, Yong-Gao Mou, Le Wen, Bo Yang, Mu-Sheng Zeng, Min-Hua Luo, Hua Zhang
EphA2 is a functional entry receptor for HCMV infection of glioblastoma cells. PLoS pathogens 19 (5) (2023)
Chang-Mi Deng, Tong-Min Wang, Yong-Qiao He, Wen-Li Zhang, Wen-Qiong Xue, Dan-Hua Li, Da-Wei Yang, Qiao-Ling Wang, Ying Liao, Hua Diao, Cheng-Tao Jiang, Jiang-Bo Zhang, Lei-Lei Yuan, Xue-Yin Chen, Ting Zhou, Xi-Zhao Li, Pei-Fen Zhang, Xiao-Hui Zheng, Shao-Dan Zhang, Ye-Zhu Hu, Miao Xu, Mu-Sheng Zeng, Lin Feng, Wei-Hua Jia
Peptidome-wide association analysis of Epstein-Barr virus identifies epitope repertoires associated with nasopharyngeal carcinoma. Journal of medical virology 95 (6) (2023)
Zheng-Zhou Lu, Cong Sun, Xiaolin Zhang, Yingying Peng, Yan Wang, Yan Zeng, Nannan Zhu, Yan Yuan, Mu-Sheng Zeng
Neuropilin 1 is an entry receptor for KSHV infection of mesenchymal stem cell through TGFBR1/2-mediated macropinocytosis. Science advances 9 (21) (2023)
Ge-Xin Zhao, Guo-Long Bu, Gang-Feng Liu, Xiang-Wei Kong, Cong Sun, Zi-Qian Li, Dan-Ling Dai, Hai-Xia Sun, Yin-Feng Kang, Guo-Kai Feng, Qian Zhong, Mu-Sheng Zeng
mRNA-based Vaccines Targeting the T-cell Epitope-rich Domain of Epstein Barr Virus Latent Proteins Elicit Robust Anti-Tumor Immunity in Mice. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
Chong Wang, Xiang Liu, Jun Liang, Yohei Narita, Weiyue Ding, Difei Li, Luyao Zhang, Hongbo Wang, Merrin Man Long Leong, Isabella Hou, Catherine Gerdt, Chang Jiang, Qian Zhong, Zhonghui Tang, Carmy Forney, Leah C Kottyan, Matthew T Weirauch, Benjamin E Gewurz, Mu-Sheng Zeng, Sizun J Jiang, Mingxiang Teng, Bo Zhao
A DNA tumor virus globally reprograms host 3D genome architecture to achieve immortal growth. Nature communications 14 (1) (2023)
Xiao-Dong Dong, Yan Li, Ying Li, Cong Sun, Shang-Xin Liu, Hao Duan, Run Cui, Qian Zhong, Yong-Gao Mou, Le Wen, Bo Yang, Mu-Sheng Zeng, Min-Hua Luo, Hua Zhang
EphA2 is a functional entry receptor for HCMV infection of glioblastoma cells. PLoS pathogens 19 (5) (2023)
Xiao-Dong Dong, Yan Li, Ying Li, Cong Sun, Shang-Xin Liu, Hao Duan, Run Cui, Qian Zhong, Yong-Gao Mou, Le Wen, Bo Yang, Mu-Sheng Zeng, Min-Hua Luo, Hua Zhang
EphA2 is a functional entry receptor for HCMV infection of glioblastoma cells. PLoS pathogens 19 (5) (2023)
Xiao-Dong Dong, Yan Li, Ying Li, Cong Sun, Shang-Xin Liu, Hao Duan, Run Cui, Qian Zhong, Yong-Gao Mou, Le Wen, Bo Yang, Mu-Sheng Zeng, Min-Hua Luo, Hua Zhang
EphA2 is a functional entry receptor for HCMV infection of glioblastoma cells. PLoS pathogens 19 (5) (2023)
Chu Xie, Lan-Yi Zhong, Guo-Long Bu, Ge-Xin Zhao, Bo-Yu Yuan, Yuan-Tao Liu, Cong Sun, Mu-Sheng Zeng
Anti-EBV antibodies: Roles in diagnosis, pathogenesis, and antiviral therapy. Journal of medical virology 95 (5) (2023)
Chong Wang, Xiang Liu, Jun Liang, Yohei Narita, Weiyue Ding, Difei Li, Luyao Zhang, Hongbo Wang, Merrin Man Long Leong, Isabella Hou, Catherine Gerdt, Chang Jiang, Qian Zhong, Zhonghui Tang, Carmy Forney, Leah C Kottyan, Matthew T Weirauch, Benjamin E Gewurz, Mu-Sheng Zeng, Sizun J Jiang, Mingxiang Teng, Bo Zhao
A DNA tumor virus globally reprograms host 3D genome architecture to achieve immortal growth. Nature communications 14 (1) (2023)
Xiao-Dong Dong, Yan Li, Ying Li, Cong Sun, Shang-Xin Liu, Hao Duan, Run Cui, Qian Zhong, Yong-Gao Mou, Le Wen, Bo Yang, Mu-Sheng Zeng, Min-Hua Luo, Hua Zhang
EphA2 is a functional entry receptor for HCMV infection of glioblastoma cells. PLoS pathogens 19 (5) (2023)
Chong Wang, Xiang Liu, Jun Liang, Yohei Narita, Weiyue Ding, Difei Li, Luyao Zhang, Hongbo Wang, Merrin Man Long Leong, Isabella Hou, Catherine Gerdt, Chang Jiang, Qian Zhong, Zhonghui Tang, Carmy Forney, Leah C Kottyan, Matthew T Weirauch, Benjamin E Gewurz, Mu-Sheng Zeng, Sizun J Jiang, Mingxiang Teng, Bo Zhao
A DNA tumor virus globally reprograms host 3D genome architecture to achieve immortal growth. Nature communications 14 (1) (2023)
Li Yuan, Guo-Dong Jia, Xiao-Fei Lv, Si-Yi Xie, Shan-Shan Guo, Da-Feng Lin, Li-Ting Liu, Dong-Hua Luo, Yi-Fu Li, Shen-Wen Deng, Ling Guo, Mu-Sheng Zeng, Xiu-Yu Cai, Sai-Lan Liu, Xue-Song Sun, Xiao-Yun Li, Su-Chen Li, Qiu-Yan Chen, Lin-Quan Tang, Hai-Qiang Mai
Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trial. Nature communications 14 (1) (2023)
Nannan Zhu, Qian Wang, Zhidong Wu, Yan Wang, Mu-Sheng Zeng, Yan Yuan
Epstein-Barr Virus LMP1-Activated mTORC1 and mTORC2 Coordinately Promote Nasopharyngeal Cancer Stem Cell Properties. Journal of virology 96 (5) (2022)
Yin-Feng Kang, Cong Sun, Jing Sun, Chu Xie, Zhen Zhuang, Hui-Qin Xu, Zheng Liu, Yi-Hao Liu, Sui Peng, Run-Yu Yuan, Jin-Cun Zhao, Mu-Sheng Zeng
Quadrivalent mosaic HexaPro-bearing nanoparticle vaccine protects against infection of SARS-CoV-2 variants. Nature communications 13 (1) (2022)
Junping Hong, Ling Zhong, Qingbing Zheng, Qian Wu, Zhenghui Zha, Dongmei Wei, Haiwen Chen, Wanlin Zhang, Shanshan Zhang, Yang Huang, Kaiyun Chen, Junyu Chen, Shao-Wei Li, Mu-Sheng Zeng, Yi-Xin Zeng, Ningshao Xia, Xiao Zhang, Miao Xu, Yixin Chen
A Neutralizing Antibody Targeting gH Provides Potent Protection against EBV Challenge In Vivo . Journal of virology 96 (8) (2022)
Cong Sun, Run-Yu Yuan, Chu Xie, Jiu-Feng Sun, Xin-Yan Fang, Yi-Sha Hu, Xiao-Hui Yu, Zheng Liu, Mu-Sheng Zeng, Yin-Feng Kang
Induction of Broadly Cross-Reactive Antibody Responses to SARS-CoV-2 Variants by S1 Nanoparticle Vaccines. Journal of virology 96 (13) (2022)
Ling Zhong, Claude Krummenacher, Wanlin Zhang, Junping Hong, Qisheng Feng, Yixin Chen, Qinjian Zhao, Mu-Sheng Zeng, Yi-Xin Zeng, Xiaoxue Chen, Xiao Zhang
Urgency and necessity of Epstein-Barr virus prophylactic vaccines. NPJ vaccines 7 (1) (2022)
Xiao Zhang, Junping Hong, Ling Zhong, Qian Wu, Shanshan Zhang, Qianying Zhu, Haiwen Chen, Dongmei Wei, Rui Li, Wanlin Zhang, Xinyu Zhang, Guosong Wang, Xiang Zhou, Junyu Chen, Yinfeng Kang, Zhenghui Zha, Xiaobing Duan, Yang Huang, Cong Sun, Xiangwei Kong, Yan Zhou, Yanhong Chen, Xiaoping Ye, Qisheng Feng, Shaowei Li, Tong Xiang, Song Gao, Mu-Sheng Zeng, Qingbing Zheng, Yixin Chen, Yi-Xin Zeng, Ning-Shao Xia, Xiaoxue Chen
Protective anti-gB neutralizing antibodies targeting two vulnerable sites for EBV-cell membrane fusion. Proceedings of the National Academy of Sciences of the United States of America 119 (32) (2022)
Xiang-Wei Kong, Xiao Zhang, Guo-Long Bu, Hui-Qin Xu, Yin-Feng Kang, Cong Sun, Qian-Ying Zhu, Run-Bo Ma, Zheng Liu, Yi-Xin Zeng, Mu-Sheng Zeng, Zhu-Long Hu
Vesicular Stomatitis Virus-Based Epstein-Barr Virus Vaccines Elicit Strong Protective Immune Responses. Journal of virology 96 (9) (2022)
Ling Zhong, Claude Krummenacher, Wanlin Zhang, Junping Hong, Qisheng Feng, Yixin Chen, Qinjian Zhao, Mu-Sheng Zeng, Yi-Xin Zeng, Xiaoxue Chen, Xiao Zhang
Urgency and necessity of Epstein-Barr virus prophylactic vaccines. NPJ vaccines 7 (1) (2022)
Ling Zhong, Claude Krummenacher, Wanlin Zhang, Junping Hong, Qisheng Feng, Yixin Chen, Qinjian Zhao, Mu-Sheng Zeng, Yi-Xin Zeng, Xiaoxue Chen, Xiao Zhang
Urgency and necessity of Epstein-Barr virus prophylactic vaccines. NPJ vaccines 7 (1) (2022)
Cong Sun, Yin-Feng Kang, Yuan-Tao Liu, Xiang-Wei Kong, Hui-Qin Xu, Dan Xiong, Chu Xie, Yi-Hao Liu, Sui Peng, Guo-Kai Feng, Zheng Liu, Mu-Sheng Zeng
Parallel profiling of antigenicity alteration and immune escape of SARS-CoV-2 Omicron and other variants. Signal transduction and targeted therapy 7 (1) (2022)
Yin-Feng Kang, Cong Sun, Zhen Zhuang, Run-Yu Yuan, Qingbing Zheng, Jiang-Ping Li, Ping-Ping Zhou, Xin-Chun Chen, Zhe Liu, Xiao Zhang, Xiao-Hui Yu, Xiang-Wei Kong, Qian-Ying Zhu, Qian Zhong, Miao Xu, Nan-Shan Zhong, Yi-Xin Zeng, Guo-Kai Feng, Changwen Ke, Jin-Cun Zhao, Mu-Sheng Zeng
Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates. ACS nano 15 (2) (2021)
Tian-Liang Xia, Xingyang Li, Xueping Wang, Yun-Jia Zhu, Hua Zhang, Weisheng Cheng, Mei-Ling Chen, Ying Ye, Yan Li, Ao Zhang, Dan-Ling Dai, Qian-Ying Zhu, Li Yuan, Jian Zheng, Huilin Huang, Si-Qi Chen, Zhi-Wen Xiao, Hong-Bo Wang, Gaurab Roy, Qian Zhong, Dongxin Lin, Yi-Xin Zeng, Jinkai Wang, Bo Zhao, Benjamin E Gewurz, Jianjun Chen, Zhi-Xiang Zuo, Mu-Sheng Zeng
N(6)-methyladenosine-binding protein YTHDF1 suppresses EBV replication and promotes EBV RNA decay. EMBO reports 22 (4) (2021)
Qian-Ying Zhu, Sisi Shan, Jinfang Yu, Si-Ying Peng, Cong Sun, Yanan Zuo, Lan-Yi Zhong, Shu-Mei Yan, Xiao Zhang, Ziqing Yang, Yong-Jian Peng, Xuanling Shi, Su-Mei Cao, Xinquan Wang, Mu-Sheng Zeng, Linqi Zhang
A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus. Nature communications 12 (1) (2021)
Yin-Feng Kang, Xiao Zhang, Xiao-Hui Yu, Qingbing Zheng, Zhe Liu, Jiang-Ping Li, Cong Sun, Xiang-Wei Kong, Qian-Ying Zhu, Hai-Wen Chen, Yang Huang, Miao Xu, Qian Zhong, Yi-Xin Zeng, Mu-Sheng Zeng
Immunization with a Self-Assembled Nanoparticle Vaccine Elicits Potent Neutralizing Antibody Responses against EBV Infection. Nano letters 21 (6) (2021)
Qian-Ying Zhu, Xiang-Wei Kong, Cong Sun, Shang-Hang Xie, Allan Hildesheim, Su-Mei Cao, Mu-Sheng Zeng
Association between Antibody Responses to Epstein-Barr Virus Glycoproteins, Neutralization of Infectivity, and the Risk of Nasopharyngeal Carcinoma. mSphere 5 (6) (2020)
Zhihai Li, Xiao Zhang, Lili Dong, Jingjing Pang, Xiaoxue Chen, Qian Zhong, Mu-Sheng Zeng, Xuekui Yu
CryoEM structure of the tegumented capsid of Epstein-Barr virus. Cell research 30 (10) (2020)
Shanzhao Jin, Ruoyan Li, Ming-Yuan Chen, Chao Yu, Lin-Quan Tang, Yan-Min Liu, Jiang-Ping Li, Yi-Na Liu, Yi-Ling Luo, Yifan Zhao, Yu Zhang, Tian-Liang Xia, Shang-Xin Liu, Qi Liu, Guan-Nan Wang, Rui You, Jing-Yun Peng, Jiang Li, Feng Han, Jianwei Wang, Qiu-Yan Chen, Li Zhang, Hai-Qiang Mai, Benjamin E Gewurz, Bo Zhao, Lawrence S Young, Qian Zhong, Fan Bai, Mu-Sheng Zeng
Single-cell transcriptomic analysis defines the interplay between tumor cells, viral infection, and the microenvironment in nasopharyngeal carcinoma. Cell research 30 (11) (2020)
Ao Zhang, Junji Xing, Tianliang Xia, Hua Zhang, Mingli Fang, Shibing Li, Yong Du, Xian C Li, Zhiqiang Zhang, Mu-Sheng Zeng
EphA2 phosphorylates NLRP3 and inhibits inflammasomes in airway epithelial cells. EMBO reports 21 (7) (2020)
Hui-Ping He, Meng Luo, Yu-Lu Cao, Yu-Xin Lin, Hua Zhang, Xiao Zhang, Jun-Ying Ou, Bing Yu, Xiaoxue Chen, Miao Xu, Lin Feng, Mu-Sheng Zeng, Yi-Xin Zeng, Song Gao
Structure of Epstein-Barr virus tegument protein complex BBRF2-BSRF1 reveals its potential role in viral envelopment. Nature communications 11 (1) (2020)
Jia Liu, Ze-Xian Liu, Qi-Nian Wu, Yun-Xin Lu, Chau-Wei Wong, Lei Miao, Yun Wang, Zixian Wang, Ying Jin, Ming-Ming He, Chao Ren, De-Shen Wang, Dong-Liang Chen, Heng-Ying Pu, Lin Feng, Bo Li, Dan Xie, Mu-Sheng Zeng, Peng Huang, Aifu Lin, Dongxin Lin, Rui-Hua Xu, Huai-Qiang Ju
Long noncoding RNA AGPG regulates PFKFB3-mediated tumor glycolytic reprogramming. Nature communications 11 (1) (2020)
Shi-Bing Li, Yan-Yan Liu, Li Yuan, Ming-Fang Ji, Ao Zhang, Hui-Yu Li, Lin-Quan Tang, Shuo-Gui Fang, Hua Zhang, Shan Xing, Man-Zhi Li, Qian Zhong, Shao-Jun Lin, Wan-Li Liu, Peng Huang, Yi-Xin Zeng, Yu-Ming Zheng, Zhi-Qiang Ling, Jian-Hua Sui, Mu-Sheng Zeng
Autocrine INSL5 promotes tumor progression and glycolysis via activation of STAT5 signaling. EMBO molecular medicine 12 (9) (2020)
Miao Xu, Youyuan Yao, Hui Chen, Shanshan Zhang, Su-Mei Cao, Zhe Zhang, Bing Luo, Zhiwei Liu, Zilin Li, Tong Xiang, Guiping He, Qi-Sheng Feng, Li-Zhen Chen, Xiang Guo, Wei-Hua Jia, Ming-Yuan Chen, Xiao Zhang, Shang-Hang Xie, Roujun Peng, Ellen T Chang, Vincent Pedergnana, Lin Feng, Jin-Xin Bei, Rui-Hua Xu, Mu-Sheng Zeng, Weimin Ye, Hans-Olov Adami, Xihong Lin, Weiwei Zhai, Yi-Xin Zeng, Jian-Jun Liu
Genome sequencing analysis identifies Epstein-Barr virus subtypes associated with high risk of nasopharyngeal carcinoma. Nature genetics 51 (7) (2019)
Bu-Shu Xu, Huo-Ying Chen, Yi Que, Wei Xiao, Mu-Sheng Zeng, Xing Zhang
ALKATI interacts with c-Myc and promotes cancer stem cell-like properties in sarcoma. Oncogene 39 (1) (2019)
Lei Gao, Yong Hu, Yahui Tian, Zhenzhen Fan, Kun Wang, Hongdan Li, Qian Zhou, Guandi Zeng, Xin Hu, Lei Yu, Shiyu Zhou, Xinyuan Tong, Hsinyi Huang, Haiquan Chen, Qing-Song Liu, Wanting Liu, Gong Zhang, Mu-Sheng Zeng, Guang-Biao Zhou, Qing-Yu He, Hongbin Ji, Liang Chen
Lung cancer deficient in the tumor suppressor GATA4 is sensitive to TGFBR1 inhibition. Nature communications 10 (1) (2019)
Jialiang Zhang, Ruihong Bai, Mei Li, Huilin Ye, Chen Wu, Chengfeng Wang, Shengping Li, Liping Tan, Dongmei Mai, Guolin Li, Ling Pan, Yanfen Zheng, Jiachun Su, Ying Ye, Zhiqiang Fu, Shangyou Zheng, Zhi-Xiang Zuo, Ze-Xian Liu, Qi Zhao, Xu Che, Dan Xie, Weihua Jia, Mu-Sheng Zeng, Wen Tan, Rufu Chen, Rui-Hua Xu, Jian Zheng, Dongxin Lin
Excessive miR-25-3p maturation via N6-methyladenosine stimulated by cigarette smoke promotes pancreatic cancer progression. Nature communications 10 (1) (2019)
Wen-Hui Chen, Mu-Yan Cai, Jia-Xing Zhang, Feng-Wei Wang, Lin-Quan Tang, Yi-Ji Liao, Xiao-Han Jin, Chen-Yuan Wang, Ling Guo, Yi-Guo Jiang, Cai-Ping Ren, Hai-Qiang Mai, Mu-Sheng Zeng, Hsiang-Fu Kung, Chao-Nan Qian, Dan Xie
FMNL1 mediates nasopharyngeal carcinoma cell aggressiveness by epigenetically upregulating MTA1. Oncogene 37 (48) (2018)
Hua Zhang, Yan Li, Hong-Bo Wang, Ao Zhang, Mei-Ling Chen, Zhi-Xin Fang, Xiao-Dong Dong, Shi-Bing Li, Yong Du, Dan Xiong, Jiang-Yi He, Man-Zhi Li, Yan-Min Liu, Ai-Jun Zhou, Qian Zhong, Yi-Xin Zeng, Elliott Kieff, Zhiqiang Zhang, Benjamin E Gewurz, Bo Zhao, Mu-Sheng Zeng
Ephrin receptor A2 is an epithelial cell receptor for Epstein-Barr virus entry. Nature microbiology 3 (2) (2018)
Jin-Yu Yang, Xiang-Yu Deng, Yi-Sheng Li, Xian-Cai Ma, Jian-Xiong Feng, Bing Yu, Yang Chen, Yi-Ling Luo, Xi Wang, Mei-Ling Chen, Zhi-Xin Fang, Fu-Xiang Zheng, Yi-Ping Li, Qian Zhong, Tie-Bang Kang, Li-Bing Song, Rui-Hua Xu, Mu-Sheng Zeng, Wei Chen, Hui Zhang, Wei Xie, Song Gao
Structure of Schlafen13 reveals a new class of tRNA/rRNA- targeting RNase engaged in translational control. Nature communications 9 (1) (2018)
Lei Liu, Yi Yang, Shihua Liu, Tianyu Tao, Junchao Cai, Jueheng Wu, Hongyu Guan, Xun Zhu, Zhenjian He, Jun Li, Erwei Song, Mu-Sheng Zeng, Meng-Feng Li
EGF-induced nuclear localization of SHCBP1 activates β-catenin signaling and promotes cancer progression. Oncogene 38 (5) (2018)
Shi-Tong Yu, Qian Zhong, Ren-Hui Chen, Ping Han, Shi-Bing Li, Hua Zhang, Li Yuan, Tian-Liang Xia, Mu-Sheng Zeng, Xiao-Ming Huang
CRLF1 promotes malignant phenotypes of papillary thyroid carcinoma by activating the MAPK/ERK and PI3K/AKT pathways. Cell death & disease 9 (3) (2018)
Tong Xiang, Yu-Xin Lin, Wenlong Ma, Hao-Jiong Zhang, Ke-Ming Chen, Gui-Ping He, Xiao Zhang, Miao Xu, Qi-Sheng Feng, Ming-Yuan Chen, Mu-Sheng Zeng, Yi-Xin Zeng, Lin Feng
Vasculogenic mimicry formation in EBV-associated epithelial malignancies. Nature communications 9 (1) (2018)

Mu-Sheng Zeng.css-eqlu8i{font-size:small;padding-left:4px;} (Musheng Zeng)

Publication Activity (10 Years)

Top Topics

Top Venues

Mu-Sheng Zeng (Musheng Zeng)